Learn more

FK SLAVYANSKAYA APTEKA LTD

Overview
  • Total Patents
    20
About

FK SLAVYANSKAYA APTEKA LTD has a total of 20 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EAPO (Eurasian Patent Organization). Its main competitors in its focus markets pharmaceuticals are EMBERA NEUROTHERAPEUTICS INC, ONCORENA AB and MENDOZA WENDELL G.

Patent filings in countries

World map showing FK SLAVYANSKAYA APTEKA LTDs patent filings in countries
# Country Total Patents
#1 EAPO (Eurasian Patent Organization) 20

Patent filings per year

Chart showing FK SLAVYANSKAYA APTEKA LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 Chelyaeva Anastasiya Gennadievna 20
#2 Lobko Vladimir Pavlovich 20
#3 Tikhonenko Oleg Olegovich 10

Latest patents

Publication Filing date Title
EA020404B1 Pharmaceutical composition comprising calcium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020389B1 Pharmaceutical composition comprising sodium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020403B1 Pharmaceutical composition comprising sodium, calcium, magnesium, iron and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020388B1 Pharmaceutical composition comprising sodium, calcium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020405B1 Pharmaceutical composition comprising sodium, magnesium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020402B1 Pharmaceutical composition comprising sodium, calcium, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020406B1 Pharmaceutical composition comprising calcium, magnesium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020361B1 Pharmaceutical composition comprising magnesium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020362B1 Pharmaceutical composition comprising sodium, calcium, magnesium, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA020401B1 Pharmaceutical composition comprising sodium, calcium, magnesium, iron, zinc and having a metabolic, anti-cataract, retina-protecting effect (variants)
EA021234B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021248B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021247B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021232B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021266B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021246B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021233B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021231B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021295B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021265B1 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)